{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:15:12Z","timestamp":1762312512846,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008249","name":"Frimodt-Heineke Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020035","name":"A. P. M\u00f8llerske St\u00f8ttefond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008274","name":"P. A. Messerschmidt og Hustrus Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jcrc.2025.155083","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T23:34:03Z","timestamp":1744760043000},"page":"155083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nitric oxide biomarkers and circulatory failure in critical illness: A cohort study"],"prefix":"10.1016","volume":"88","author":[{"given":"Karoline Mygleg\u00e5rd","family":"Mortensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten Heiberg","family":"Bestle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Stensballe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thore","family":"Hillig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Antonio Juel","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Sch\u00f8nemann-Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theis Skovsgaard","family":"Itenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2025.155083_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcrc.2021.05.023","article-title":"Definition and incidence of hypotension in intensive care unit patients, an international survey of the European society of intensive care medicine","volume":"65","author":"Schenk","year":"2021","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2025.155083_bb0010","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2025.155083_bb0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00134-016-4237-3","article-title":"Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial","volume":"42","author":"Lamontagne","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2025.155083_bb0020","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2020.0930","article-title":"Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial","volume":"323","author":"Lamontagne","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2025.155083_bb0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jcrc.2021.10.008","article-title":"Monitoring, management, and outcome of hypotension in intensive care unit patients, an international survey of the European society of intensive care medicine","volume":"67","author":"van der Ven","year":"2022","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2025.155083_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.CCM.0000105118.66983.19","article-title":"Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo","volume":"32","author":"Bakker","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2025.155083_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock","volume":"32","author":"L\u00f3pez","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2025.155083_bb0040","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00134-010-1970-x","article-title":"The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients","volume":"36","author":"Boerma","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2025.155083_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1567-5688(03)00032-1","article-title":"The DDAH\/ADMA\/NOS pathway","volume":"Suppl. 4","author":"Tran","year":"2003","journal-title":"Atheroscler"},{"key":"10.1016\/j.jcrc.2025.155083_bb0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13054-022-04075-0","article-title":"A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach","volume":"26","author":"Singh","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155083_bb0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B","volume":"1","author":"Closs","year":"1997","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jcrc.2025.155083_bb0060","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.1021\/bi980742t","article-title":"Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine","volume":"37","author":"Moali","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jcrc.2025.155083_bb0065","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00726-015-2017-y","article-title":"Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease","volume":"47","author":"Papageorgiou","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.jcrc.2025.155083_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13054-021-03877-y","article-title":"Endotheliopathy is associated with slower liberation from mechanical ventilation: a cohort study","volume":"26","author":"Sch\u00f8nemann-Lund","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155083_bb0075","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/aas.14246","article-title":"Novel subgroups in acute respiratory failure based on the trajectories of three endotheliopathy biomarkers: a cohort study","volume":"67","author":"Sch\u00f8nemann-Lund","year":"2023","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jcrc.2025.155083_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40001-023-01612-7","article-title":"LASSO regression shows histidine and sphingosine 1 phosphate are linked to both sepsis mortality and endothelial damage","volume":"29","author":"Johansson","year":"2024","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155083_bb0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13613-024-01362-7","article-title":"Changes in nitric oxide inhibitors and mortality in critically ill patients: a cohort study","volume":"14","author":"Mortensen","year":"2024","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jcrc.2025.155083_bb0090","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2025.155083_bb0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jcrc.2025.155083_bb0100","series-title":"Clerical changes for implementation of adding serum sodium to the MELD score","first-page":"4","author":"Liver and Intestinal Organ Transplanation Committee - OPTN\/UNOS","year":"2015"},{"author":"Mortensen","key":"10.1016\/j.jcrc.2025.155083_bb0105"},{"year":"1991","series-title":"Practical Statistics for Medical Research","author":"Altman","key":"10.1016\/j.jcrc.2025.155083_bb0110"},{"author":"Winter","key":"10.1016\/j.jcrc.2025.155083_bb0115"},{"year":"2023","series-title":"R: a language and environment for statistical computing","author":"R Core Team","key":"10.1016\/j.jcrc.2025.155083_bb0120"},{"key":"10.1016\/j.jcrc.2025.155083_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1054\/clnu.2002.0612","article-title":"The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)","volume":"22","author":"Nijveldt","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcrc.2025.155083_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1054\/clnu.2002.0613","article-title":"Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality","volume":"22","author":"Nijveldt","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcrc.2025.155083_bb0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","article-title":"Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans","volume":"109","author":"Kielstein","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2025.155083_bb0140","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"Achan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcrc.2025.155083_bb0145","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1161\/01.CIR.96.11.3897","article-title":"Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans","volume":"96","author":"Owlya","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2025.155083_bb0150","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1152\/ajpregu.2001.280.5.R1494","article-title":"NO modulates norepinephrine release in human skeletal muscle: implications for neural preconditioning","volume":"280","author":"Costa","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jcrc.2025.155083_bb0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.ASN.0000106717.58091.F6","article-title":"Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease","volume":"15","author":"Mallamaci","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcrc.2025.155083_bb0160","first-page":"305","article-title":"Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS","author":"Elms","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jcrc.2025.155083_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0928-4680(98)80513-0","article-title":"Arginine metabolism and nitric oxide production","volume":"5","author":"Mori","year":"1998","journal-title":"Pathophysiology"},{"key":"10.1016\/j.jcrc.2025.155083_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(00)01686-0","article-title":"Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox","volume":"478","author":"Tsikas","year":"2000","journal-title":"FEBS Lett"},{"year":"2007","series-title":"The L-arginine paradox: importance of the L-arginine\/asymmetrical dimethylarginine ratio","author":"Bode-B\u00f6ger","key":"10.1016\/j.jcrc.2025.155083_bb0175"},{"key":"10.1016\/j.jcrc.2025.155083_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.niox.2022.03.002","article-title":"ADMA and homoarginine independently predict mortality in critically ill patients","volume":"122\u2013123","author":"Lee","year":"2022","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jcrc.2025.155083_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/eci.12960","article-title":"Homoarginine and all-cause mortality: a systematic review and meta-analysis","volume":"48","author":"Zinellu","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jcrc.2025.155083_bb0190","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/HJH.0b013e32836037fb","article-title":"L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study","volume":"31","author":"Van Der Zwan","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.jcrc.2025.155083_bb0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/SHK.0000000000000649","article-title":"High levels of methylarginines were associated with increased mortality in patients with severe sepsis","volume":"46","author":"Mortensen","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.jcrc.2025.155083_bb0200","first-page":"1","article-title":"Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis","author":"Koch","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jcrc.2025.155083_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jcrc.2013.05.016","article-title":"Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients","volume":"28","author":"Koch","year":"2013","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2025.155083_bb0210","article-title":"From macrohemodynamic to the microcirculation","author":"Donati","year":"2013","journal-title":"Crit Care Res Prac"},{"key":"10.1016\/j.jcrc.2025.155083_bb0215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2025.155083_bb0220","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2025.155083_bb0225","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2025.155083_bb0230","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1389203719666181026170049","article-title":"Novel biosynthesis, metabolism and physiological functions of L-Homoarginine","volume":"20","author":"Adams","year":"2019","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.jcrc.2025.155083_bb0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/acb.2009.009196","article-title":"The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine","volume":"47","author":"Blackwell","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jcrc.2025.155083_bb0240","first-page":"1","article-title":"Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies","author":"Schlesinger","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jcrc.2025.155083_bb0245","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1097\/CCM.0000000000000549","article-title":"Randomized controlled trial of inhaled nitric oxide for the treatment of microcirculatory dysfunction in patients with sepsis","volume":"42","author":"Trzeciak","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2025.155083_bb0250","first-page":"1","article-title":"Methylene blue reduces mortality in critically ill and perioperative patients: a meta-analysis of randomized trials","volume":"000","author":"Pruna","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jcrc.2025.155083_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-023-04397-7","article-title":"Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial","volume":"27","author":"Ibarra-Estrada","year":"2023","journal-title":"Crit Care"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412500070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412500070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:11:09Z","timestamp":1762312269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394412500070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"alternative-id":["S088394412500070X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155083","relation":{},"ISSN":["0883-9441"],"issn-type":[{"type":"print","value":"0883-9441"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide biomarkers and circulatory failure in critical illness: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155083"}}